UNITY Biotechnology Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$243.6M
Industry:Biotech
Founded:2009
Lead Investor(s):EcoR1 Capital Fund, 6 Dimensions Capital

Industry Ranking

Estimated Revenue & Financials

  • UNITY Biotechnology's estimated annual revenue is currently $16.1M per year.
  • UNITY Biotechnology received $55.0M in venture funding in March 2018.
  • UNITY Biotechnology's estimated revenue per employee is $155,000
  • UNITY Biotechnology's total funding is $243.6M.

Employee Data

  • UNITY Biotechnology has 104 Employees.
  • UNITY Biotechnology grew their employee count by -13% last year.
  • UNITY Biotechnology currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$7M4510%N/A-N/A
#2
N/A205N/AN/A-N/A
#3
$46.8M3024%N/A-N/A
#4
$22.3M144N/AN/A-N/A
#5
$44.3M286N/AN/A-N/A
#6
$101.2M65346%N/A-N/A
#7
$18.6M120N/AN/A-N/A
#8
$23.3M150N/AN/A-N/A
#9
$33.3M2153%N/A-N/A
#10
$28.7M1858%N/A-N/A
Missing a competitor? Contribute!?
Submit

UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com.

keywords:N/A

104

Number of Employees

$16.1M

Revenue (est)

1

Current Jobs

-13%

Employee Growth %

$243.6M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

UNITY Biotechnology News

24-Aug-19 - Unity Biotech: Buy at the Low?

Unity Biotech (NASDAQ:UBX) is developing drug candidates to extend the number of years humans can live unburdened by disease, but ...

12-Sep-19 - Why Unity Biotechnology, Inc. (UBX) Stock Is Killing It Today – Soaring 3.57%

Unity Biotechnology, Inc. (NASDAQ:UBX) is one of the stocks that are grabbing investor focus today: skyrocketing 3.57% or (0.28 points) to ...

31-Aug-19 - UNITY Biotechnology, Inc. to Participate in Upcoming Investor ...

27, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$16.1M104N/AN/A-N/A
#2
$15.2M105N/AN/A-N/A
#3
$22.1M105N/AN/A-N/A
#4
$10.5M105N/AN/A-N/A
#5
$33.9M105N/AN/A-N/A

UNITY Biotechnology Funding

DateAmountRoundLead InvestorsReference
2016-10-28$116.0MBArticle
2017-08-18$35.0MBMultipleArticle
2018-03-20$55.0MCEcoR1 Capital FundArticle

UNITY Biotechnology Executive Hires

DateNameTitleReference
2017-09-22Bob GoeltzChief Financial OfficerArticle
2018-05-15Camille LandisSVP Corporate DevelopmentArticle